Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
| Image |  |
|---|---|
| Description | scientific article published on 29 September 2020 |
| Author/s |
author: Prodromos Sidiropoulos |
| Publication date | September 29, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |